Arthritis & Rheumatology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=532250, encodeId=30255322507d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Arthritis & Rheumatology changed its title from Arthritis & Rheumatism. The 2015 Impact Factor for Arthritis & Rheumatism is 8.955 and it is ranked 3rd out of 32 journals in the Rheumatology category in the 2016 edition of Journal Citation Reports?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dfa2010504, createdName=ccdaxiaoduoshao, createdTime=Wed Jan 25 08:46:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138039, encodeId=6dac2138039da, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59988692904, createdName=ms7000002111886847, createdTime=Sat May 20 17:30:55 CST 2023, time=2023-05-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1083446, encodeId=87791083446e7, content=从article received 三天到under review，再过一天到EIC decision，感觉凉了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=715, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Thu Dec 23 08:16:24 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119367, encodeId=ef52211936e5d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Timeline: 2022.12.14 第一次投初稿； 2023.02.03 给了major revision，2个审稿人，另外编辑还有一些comments，三位的审稿意见有重合，需要补一些敏感性分析（ps: 我还是第一次回编辑意见回的比审稿人长）； 2023.02.13 补完了分析，敏感性分析结果和main results差不多； 2023.03.10 第二次Under review结束，给回意见accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Tue Mar 14 17:12:47 CST 2023, time=2023-03-14, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=509628, encodeId=05785096282a, content=刚有篇文章被接受了。很高兴！前后共用的近半年时间。大修2次，小修2次。对语言要求很高，找外籍修过两次才过关。编辑审稿很务实，讲求文章的实用性。特别考虑读者的可读性！very nice!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=580c83857, createdName=yeqingkao, createdTime=Sat Feb 07 08:54:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224711, encodeId=6af81224e1167, content=有没有中过的兄弟分享一下从投稿到接收的状态变化都有什么？每个阶段大概多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1222355201, createdName=122bcca1m71(暂无昵称), createdTime=Mon Jun 06 11:52:44 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087476, encodeId=9f6c108e47625, content=如何提炼/撰写文章题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=657, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087475, encodeId=cefe108e475c9, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578734, encodeId=b39c5e8734ec, content=厉害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=900, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553248, encodeId=49d45532486b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非常专业，对工作的创新性要求比较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1083, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d8a1648346, createdName=乡下人, createdTime=Sat Mar 03 19:18:00 CST 2018, time=2018-03-03, status=1, ipAttribution=)]

2017-01-25 ccdaxiaoduoshao

审稿速度:1.0 | 投稿命中率:25.0
经验分享：Arthritis & Rheumatology changed its title from Arthritis & Rheumatism. The 2015 Impact Factor for Arthritis & Rheumatism is 8.955 and it is ranked 3rd out of 32 journals in the Rheumatology category in the 2016 edition of Journal Citation Reports?

1101 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=532250, encodeId=30255322507d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Arthritis & Rheumatology changed its title from Arthritis & Rheumatism. The 2015 Impact Factor for Arthritis & Rheumatism is 8.955 and it is ranked 3rd out of 32 journals in the Rheumatology category in the 2016 edition of Journal Citation Reports?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dfa2010504, createdName=ccdaxiaoduoshao, createdTime=Wed Jan 25 08:46:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138039, encodeId=6dac2138039da, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59988692904, createdName=ms7000002111886847, createdTime=Sat May 20 17:30:55 CST 2023, time=2023-05-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1083446, encodeId=87791083446e7, content=从article received 三天到under review，再过一天到EIC decision，感觉凉了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=715, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Thu Dec 23 08:16:24 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119367, encodeId=ef52211936e5d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Timeline: 2022.12.14 第一次投初稿； 2023.02.03 给了major revision，2个审稿人，另外编辑还有一些comments，三位的审稿意见有重合，需要补一些敏感性分析（ps: 我还是第一次回编辑意见回的比审稿人长）； 2023.02.13 补完了分析，敏感性分析结果和main results差不多； 2023.03.10 第二次Under review结束，给回意见accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Tue Mar 14 17:12:47 CST 2023, time=2023-03-14, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=509628, encodeId=05785096282a, content=刚有篇文章被接受了。很高兴！前后共用的近半年时间。大修2次，小修2次。对语言要求很高，找外籍修过两次才过关。编辑审稿很务实，讲求文章的实用性。特别考虑读者的可读性！very nice!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=580c83857, createdName=yeqingkao, createdTime=Sat Feb 07 08:54:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224711, encodeId=6af81224e1167, content=有没有中过的兄弟分享一下从投稿到接收的状态变化都有什么？每个阶段大概多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1222355201, createdName=122bcca1m71(暂无昵称), createdTime=Mon Jun 06 11:52:44 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087476, encodeId=9f6c108e47625, content=如何提炼/撰写文章题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=657, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087475, encodeId=cefe108e475c9, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578734, encodeId=b39c5e8734ec, content=厉害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=900, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553248, encodeId=49d45532486b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非常专业，对工作的创新性要求比较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1083, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d8a1648346, createdName=乡下人, createdTime=Sat Mar 03 19:18:00 CST 2018, time=2018-03-03, status=1, ipAttribution=)]

2023-05-20 ms7000002111886847 来自江苏省

审稿速度:1.0 | 投稿命中率:75.0
经验分享：偏慢

80 0

[GetPortalCommentsPageByObjectIdResponse(id=532250, encodeId=30255322507d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Arthritis & Rheumatology changed its title from Arthritis & Rheumatism. The 2015 Impact Factor for Arthritis & Rheumatism is 8.955 and it is ranked 3rd out of 32 journals in the Rheumatology category in the 2016 edition of Journal Citation Reports?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dfa2010504, createdName=ccdaxiaoduoshao, createdTime=Wed Jan 25 08:46:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138039, encodeId=6dac2138039da, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59988692904, createdName=ms7000002111886847, createdTime=Sat May 20 17:30:55 CST 2023, time=2023-05-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1083446, encodeId=87791083446e7, content=从article received 三天到under review，再过一天到EIC decision，感觉凉了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=715, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Thu Dec 23 08:16:24 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119367, encodeId=ef52211936e5d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Timeline: 2022.12.14 第一次投初稿； 2023.02.03 给了major revision，2个审稿人，另外编辑还有一些comments，三位的审稿意见有重合，需要补一些敏感性分析（ps: 我还是第一次回编辑意见回的比审稿人长）； 2023.02.13 补完了分析，敏感性分析结果和main results差不多； 2023.03.10 第二次Under review结束，给回意见accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Tue Mar 14 17:12:47 CST 2023, time=2023-03-14, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=509628, encodeId=05785096282a, content=刚有篇文章被接受了。很高兴！前后共用的近半年时间。大修2次，小修2次。对语言要求很高，找外籍修过两次才过关。编辑审稿很务实，讲求文章的实用性。特别考虑读者的可读性！very nice!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=580c83857, createdName=yeqingkao, createdTime=Sat Feb 07 08:54:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224711, encodeId=6af81224e1167, content=有没有中过的兄弟分享一下从投稿到接收的状态变化都有什么？每个阶段大概多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1222355201, createdName=122bcca1m71(暂无昵称), createdTime=Mon Jun 06 11:52:44 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087476, encodeId=9f6c108e47625, content=如何提炼/撰写文章题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=657, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087475, encodeId=cefe108e475c9, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578734, encodeId=b39c5e8734ec, content=厉害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=900, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553248, encodeId=49d45532486b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非常专业，对工作的创新性要求比较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1083, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d8a1648346, createdName=乡下人, createdTime=Sat Mar 03 19:18:00 CST 2018, time=2018-03-03, status=1, ipAttribution=)]

2021-12-23 丿柚子

从article received 三天到under review，再过一天到EIC decision，感觉凉了。。。

715 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=532250, encodeId=30255322507d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Arthritis & Rheumatology changed its title from Arthritis & Rheumatism. The 2015 Impact Factor for Arthritis & Rheumatism is 8.955 and it is ranked 3rd out of 32 journals in the Rheumatology category in the 2016 edition of Journal Citation Reports?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dfa2010504, createdName=ccdaxiaoduoshao, createdTime=Wed Jan 25 08:46:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138039, encodeId=6dac2138039da, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59988692904, createdName=ms7000002111886847, createdTime=Sat May 20 17:30:55 CST 2023, time=2023-05-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1083446, encodeId=87791083446e7, content=从article received 三天到under review，再过一天到EIC decision，感觉凉了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=715, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Thu Dec 23 08:16:24 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119367, encodeId=ef52211936e5d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Timeline: 2022.12.14 第一次投初稿； 2023.02.03 给了major revision，2个审稿人，另外编辑还有一些comments，三位的审稿意见有重合，需要补一些敏感性分析（ps: 我还是第一次回编辑意见回的比审稿人长）； 2023.02.13 补完了分析，敏感性分析结果和main results差不多； 2023.03.10 第二次Under review结束，给回意见accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Tue Mar 14 17:12:47 CST 2023, time=2023-03-14, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=509628, encodeId=05785096282a, content=刚有篇文章被接受了。很高兴！前后共用的近半年时间。大修2次，小修2次。对语言要求很高，找外籍修过两次才过关。编辑审稿很务实，讲求文章的实用性。特别考虑读者的可读性！very nice!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=580c83857, createdName=yeqingkao, createdTime=Sat Feb 07 08:54:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224711, encodeId=6af81224e1167, content=有没有中过的兄弟分享一下从投稿到接收的状态变化都有什么？每个阶段大概多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1222355201, createdName=122bcca1m71(暂无昵称), createdTime=Mon Jun 06 11:52:44 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087476, encodeId=9f6c108e47625, content=如何提炼/撰写文章题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=657, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087475, encodeId=cefe108e475c9, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578734, encodeId=b39c5e8734ec, content=厉害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=900, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553248, encodeId=49d45532486b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非常专业，对工作的创新性要求比较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1083, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d8a1648346, createdName=乡下人, createdTime=Sat Mar 03 19:18:00 CST 2018, time=2018-03-03, status=1, ipAttribution=)]

2023-03-14 897400411 来自香港

审稿速度:2.0 | 投稿命中率:25.0
经验分享：Timeline:
2022.12.14 第一次投初稿；
2023.02.03 给了major revision，2个审稿人，另外编辑还有一些comments，三位的审稿意见有重合，需要补一些敏感性分析（ps: 我还是第一次回编辑意见回的比审稿人长）；
2023.02.13 补完了分析，敏感性分析结果和main results差不多；
2023.03.10 第二次Under review结束，给回意见accepted

104 0

[GetPortalCommentsPageByObjectIdResponse(id=532250, encodeId=30255322507d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Arthritis & Rheumatology changed its title from Arthritis & Rheumatism. The 2015 Impact Factor for Arthritis & Rheumatism is 8.955 and it is ranked 3rd out of 32 journals in the Rheumatology category in the 2016 edition of Journal Citation Reports?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dfa2010504, createdName=ccdaxiaoduoshao, createdTime=Wed Jan 25 08:46:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138039, encodeId=6dac2138039da, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59988692904, createdName=ms7000002111886847, createdTime=Sat May 20 17:30:55 CST 2023, time=2023-05-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1083446, encodeId=87791083446e7, content=从article received 三天到under review，再过一天到EIC decision，感觉凉了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=715, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Thu Dec 23 08:16:24 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119367, encodeId=ef52211936e5d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Timeline: 2022.12.14 第一次投初稿； 2023.02.03 给了major revision，2个审稿人，另外编辑还有一些comments，三位的审稿意见有重合，需要补一些敏感性分析（ps: 我还是第一次回编辑意见回的比审稿人长）； 2023.02.13 补完了分析，敏感性分析结果和main results差不多； 2023.03.10 第二次Under review结束，给回意见accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Tue Mar 14 17:12:47 CST 2023, time=2023-03-14, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=509628, encodeId=05785096282a, content=刚有篇文章被接受了。很高兴！前后共用的近半年时间。大修2次，小修2次。对语言要求很高，找外籍修过两次才过关。编辑审稿很务实，讲求文章的实用性。特别考虑读者的可读性！very nice!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=580c83857, createdName=yeqingkao, createdTime=Sat Feb 07 08:54:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224711, encodeId=6af81224e1167, content=有没有中过的兄弟分享一下从投稿到接收的状态变化都有什么？每个阶段大概多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1222355201, createdName=122bcca1m71(暂无昵称), createdTime=Mon Jun 06 11:52:44 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087476, encodeId=9f6c108e47625, content=如何提炼/撰写文章题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=657, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087475, encodeId=cefe108e475c9, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578734, encodeId=b39c5e8734ec, content=厉害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=900, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553248, encodeId=49d45532486b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非常专业，对工作的创新性要求比较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1083, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d8a1648346, createdName=乡下人, createdTime=Sat Mar 03 19:18:00 CST 2018, time=2018-03-03, status=1, ipAttribution=)]

2015-02-07 yeqingkao

刚有篇文章被接受了。很高兴！前后共用的近半年时间。大修2次，小修2次。对语言要求很高，找外籍修过两次才过关。编辑审稿很务实，讲求文章的实用性。特别考虑读者的可读性！very nice!

606 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=532250, encodeId=30255322507d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Arthritis & Rheumatology changed its title from Arthritis & Rheumatism. The 2015 Impact Factor for Arthritis & Rheumatism is 8.955 and it is ranked 3rd out of 32 journals in the Rheumatology category in the 2016 edition of Journal Citation Reports?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dfa2010504, createdName=ccdaxiaoduoshao, createdTime=Wed Jan 25 08:46:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138039, encodeId=6dac2138039da, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59988692904, createdName=ms7000002111886847, createdTime=Sat May 20 17:30:55 CST 2023, time=2023-05-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1083446, encodeId=87791083446e7, content=从article received 三天到under review，再过一天到EIC decision，感觉凉了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=715, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Thu Dec 23 08:16:24 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119367, encodeId=ef52211936e5d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Timeline: 2022.12.14 第一次投初稿； 2023.02.03 给了major revision，2个审稿人，另外编辑还有一些comments，三位的审稿意见有重合，需要补一些敏感性分析（ps: 我还是第一次回编辑意见回的比审稿人长）； 2023.02.13 补完了分析，敏感性分析结果和main results差不多； 2023.03.10 第二次Under review结束，给回意见accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Tue Mar 14 17:12:47 CST 2023, time=2023-03-14, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=509628, encodeId=05785096282a, content=刚有篇文章被接受了。很高兴！前后共用的近半年时间。大修2次，小修2次。对语言要求很高，找外籍修过两次才过关。编辑审稿很务实，讲求文章的实用性。特别考虑读者的可读性！very nice!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=580c83857, createdName=yeqingkao, createdTime=Sat Feb 07 08:54:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224711, encodeId=6af81224e1167, content=有没有中过的兄弟分享一下从投稿到接收的状态变化都有什么？每个阶段大概多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1222355201, createdName=122bcca1m71(暂无昵称), createdTime=Mon Jun 06 11:52:44 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087476, encodeId=9f6c108e47625, content=如何提炼/撰写文章题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=657, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087475, encodeId=cefe108e475c9, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578734, encodeId=b39c5e8734ec, content=厉害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=900, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553248, encodeId=49d45532486b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非常专业，对工作的创新性要求比较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1083, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d8a1648346, createdName=乡下人, createdTime=Sat Mar 03 19:18:00 CST 2018, time=2018-03-03, status=1, ipAttribution=)]

2022-06-06 122bcca1m71(暂无昵称)

有没有中过的兄弟分享一下从投稿到接收的状态变化都有什么？每个阶段大概多久

303 0

[GetPortalCommentsPageByObjectIdResponse(id=532250, encodeId=30255322507d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Arthritis & Rheumatology changed its title from Arthritis & Rheumatism. The 2015 Impact Factor for Arthritis & Rheumatism is 8.955 and it is ranked 3rd out of 32 journals in the Rheumatology category in the 2016 edition of Journal Citation Reports?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dfa2010504, createdName=ccdaxiaoduoshao, createdTime=Wed Jan 25 08:46:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138039, encodeId=6dac2138039da, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59988692904, createdName=ms7000002111886847, createdTime=Sat May 20 17:30:55 CST 2023, time=2023-05-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1083446, encodeId=87791083446e7, content=从article received 三天到under review，再过一天到EIC decision，感觉凉了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=715, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Thu Dec 23 08:16:24 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119367, encodeId=ef52211936e5d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Timeline: 2022.12.14 第一次投初稿； 2023.02.03 给了major revision，2个审稿人，另外编辑还有一些comments，三位的审稿意见有重合，需要补一些敏感性分析（ps: 我还是第一次回编辑意见回的比审稿人长）； 2023.02.13 补完了分析，敏感性分析结果和main results差不多； 2023.03.10 第二次Under review结束，给回意见accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Tue Mar 14 17:12:47 CST 2023, time=2023-03-14, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=509628, encodeId=05785096282a, content=刚有篇文章被接受了。很高兴！前后共用的近半年时间。大修2次，小修2次。对语言要求很高，找外籍修过两次才过关。编辑审稿很务实，讲求文章的实用性。特别考虑读者的可读性！very nice!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=580c83857, createdName=yeqingkao, createdTime=Sat Feb 07 08:54:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224711, encodeId=6af81224e1167, content=有没有中过的兄弟分享一下从投稿到接收的状态变化都有什么？每个阶段大概多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1222355201, createdName=122bcca1m71(暂无昵称), createdTime=Mon Jun 06 11:52:44 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087476, encodeId=9f6c108e47625, content=如何提炼/撰写文章题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=657, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087475, encodeId=cefe108e475c9, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578734, encodeId=b39c5e8734ec, content=厉害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=900, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553248, encodeId=49d45532486b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非常专业，对工作的创新性要求比较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1083, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d8a1648346, createdName=乡下人, createdTime=Sat Mar 03 19:18:00 CST 2018, time=2018-03-03, status=1, ipAttribution=)]

2021-12-29 乌云背后的幸福线

如何提炼/撰写文章题目？

657 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=532250, encodeId=30255322507d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Arthritis & Rheumatology changed its title from Arthritis & Rheumatism. The 2015 Impact Factor for Arthritis & Rheumatism is 8.955 and it is ranked 3rd out of 32 journals in the Rheumatology category in the 2016 edition of Journal Citation Reports?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dfa2010504, createdName=ccdaxiaoduoshao, createdTime=Wed Jan 25 08:46:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138039, encodeId=6dac2138039da, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59988692904, createdName=ms7000002111886847, createdTime=Sat May 20 17:30:55 CST 2023, time=2023-05-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1083446, encodeId=87791083446e7, content=从article received 三天到under review，再过一天到EIC decision，感觉凉了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=715, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Thu Dec 23 08:16:24 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119367, encodeId=ef52211936e5d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Timeline: 2022.12.14 第一次投初稿； 2023.02.03 给了major revision，2个审稿人，另外编辑还有一些comments，三位的审稿意见有重合，需要补一些敏感性分析（ps: 我还是第一次回编辑意见回的比审稿人长）； 2023.02.13 补完了分析，敏感性分析结果和main results差不多； 2023.03.10 第二次Under review结束，给回意见accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Tue Mar 14 17:12:47 CST 2023, time=2023-03-14, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=509628, encodeId=05785096282a, content=刚有篇文章被接受了。很高兴！前后共用的近半年时间。大修2次，小修2次。对语言要求很高，找外籍修过两次才过关。编辑审稿很务实，讲求文章的实用性。特别考虑读者的可读性！very nice!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=580c83857, createdName=yeqingkao, createdTime=Sat Feb 07 08:54:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224711, encodeId=6af81224e1167, content=有没有中过的兄弟分享一下从投稿到接收的状态变化都有什么？每个阶段大概多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1222355201, createdName=122bcca1m71(暂无昵称), createdTime=Mon Jun 06 11:52:44 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087476, encodeId=9f6c108e47625, content=如何提炼/撰写文章题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=657, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087475, encodeId=cefe108e475c9, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578734, encodeId=b39c5e8734ec, content=厉害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=900, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553248, encodeId=49d45532486b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非常专业，对工作的创新性要求比较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1083, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d8a1648346, createdName=乡下人, createdTime=Sat Mar 03 19:18:00 CST 2018, time=2018-03-03, status=1, ipAttribution=)]

2021-12-27 rayms

SCI文章有没有写作模板？

702 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=532250, encodeId=30255322507d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Arthritis & Rheumatology changed its title from Arthritis & Rheumatism. The 2015 Impact Factor for Arthritis & Rheumatism is 8.955 and it is ranked 3rd out of 32 journals in the Rheumatology category in the 2016 edition of Journal Citation Reports?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dfa2010504, createdName=ccdaxiaoduoshao, createdTime=Wed Jan 25 08:46:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138039, encodeId=6dac2138039da, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59988692904, createdName=ms7000002111886847, createdTime=Sat May 20 17:30:55 CST 2023, time=2023-05-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1083446, encodeId=87791083446e7, content=从article received 三天到under review，再过一天到EIC decision，感觉凉了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=715, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Thu Dec 23 08:16:24 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119367, encodeId=ef52211936e5d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Timeline: 2022.12.14 第一次投初稿； 2023.02.03 给了major revision，2个审稿人，另外编辑还有一些comments，三位的审稿意见有重合，需要补一些敏感性分析（ps: 我还是第一次回编辑意见回的比审稿人长）； 2023.02.13 补完了分析，敏感性分析结果和main results差不多； 2023.03.10 第二次Under review结束，给回意见accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Tue Mar 14 17:12:47 CST 2023, time=2023-03-14, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=509628, encodeId=05785096282a, content=刚有篇文章被接受了。很高兴！前后共用的近半年时间。大修2次，小修2次。对语言要求很高，找外籍修过两次才过关。编辑审稿很务实，讲求文章的实用性。特别考虑读者的可读性！very nice!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=580c83857, createdName=yeqingkao, createdTime=Sat Feb 07 08:54:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224711, encodeId=6af81224e1167, content=有没有中过的兄弟分享一下从投稿到接收的状态变化都有什么？每个阶段大概多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1222355201, createdName=122bcca1m71(暂无昵称), createdTime=Mon Jun 06 11:52:44 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087476, encodeId=9f6c108e47625, content=如何提炼/撰写文章题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=657, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087475, encodeId=cefe108e475c9, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578734, encodeId=b39c5e8734ec, content=厉害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=900, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553248, encodeId=49d45532486b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非常专业，对工作的创新性要求比较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1083, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d8a1648346, createdName=乡下人, createdTime=Sat Mar 03 19:18:00 CST 2018, time=2018-03-03, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

厉害

900 0

[GetPortalCommentsPageByObjectIdResponse(id=532250, encodeId=30255322507d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Arthritis & Rheumatology changed its title from Arthritis & Rheumatism. The 2015 Impact Factor for Arthritis & Rheumatism is 8.955 and it is ranked 3rd out of 32 journals in the Rheumatology category in the 2016 edition of Journal Citation Reports?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dfa2010504, createdName=ccdaxiaoduoshao, createdTime=Wed Jan 25 08:46:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138039, encodeId=6dac2138039da, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59988692904, createdName=ms7000002111886847, createdTime=Sat May 20 17:30:55 CST 2023, time=2023-05-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1083446, encodeId=87791083446e7, content=从article received 三天到under review，再过一天到EIC decision，感觉凉了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=715, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Thu Dec 23 08:16:24 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119367, encodeId=ef52211936e5d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Timeline: 2022.12.14 第一次投初稿； 2023.02.03 给了major revision，2个审稿人，另外编辑还有一些comments，三位的审稿意见有重合，需要补一些敏感性分析（ps: 我还是第一次回编辑意见回的比审稿人长）； 2023.02.13 补完了分析，敏感性分析结果和main results差不多； 2023.03.10 第二次Under review结束，给回意见accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Tue Mar 14 17:12:47 CST 2023, time=2023-03-14, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=509628, encodeId=05785096282a, content=刚有篇文章被接受了。很高兴！前后共用的近半年时间。大修2次，小修2次。对语言要求很高，找外籍修过两次才过关。编辑审稿很务实，讲求文章的实用性。特别考虑读者的可读性！very nice!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=580c83857, createdName=yeqingkao, createdTime=Sat Feb 07 08:54:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224711, encodeId=6af81224e1167, content=有没有中过的兄弟分享一下从投稿到接收的状态变化都有什么？每个阶段大概多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1222355201, createdName=122bcca1m71(暂无昵称), createdTime=Mon Jun 06 11:52:44 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087476, encodeId=9f6c108e47625, content=如何提炼/撰写文章题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=657, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087475, encodeId=cefe108e475c9, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578734, encodeId=b39c5e8734ec, content=厉害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=900, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553248, encodeId=49d45532486b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非常专业，对工作的创新性要求比较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1083, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d8a1648346, createdName=乡下人, createdTime=Sat Mar 03 19:18:00 CST 2018, time=2018-03-03, status=1, ipAttribution=)]

2018-03-03 乡下人

审稿速度:2.0 | 投稿命中率:25.0
经验分享：非常专业，对工作的创新性要求比较高。

1083 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

平台业务解决方案

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务